Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Background Previous research has found associations between various non-genetic factors
and breast cancer (BrCa) risk. This study summarises and appraises the credibility of the …

Radioactive iodine (RAI) therapy with iodine-131 is performed in select cases of
differentiated thyroid cancer (DTC), typically for remnant ablation, adjuvant therapy, or …

Differentiated thyroid cancer and breast cancer account for a significant portion of endocrine-
related malignancies and predominately affect women. As hormonally responsive tissues …

Background Thyroid and breast cancers are the two most frequent types of endocrine-
related tumors among women worldwide, and their incidence is still on the rise …

Second primary malignancies (SPM) are described as any primary, not synchronous,
malignancy arising in a different anatomical district, with confirmed histological diagnosis …

Hyperthyroidism is a clinical condition characterized by low thyroid-stimulating hormone
(TSH) blood levels and normal or higher blood levels of triiodothyronine (FT3) and thyroxine …

The theragnostic approach was proposed with the introduction of 131-Iodine for the
treatment of both benign and malign thyroid diseases [1–5]. The therapeutic effect of 131 …

In the adult population, the differentiated thyroid cancer (DTC) is the most frequent
endocrine neoplasm [1]. According to the American Thyroid Association (ATA) guidelines, in …

After thyroid surgery, radioiodine therapy remains the main course of treatment; giving
radioactive iodine is an essential component of the therapeutic regimen for persons with …